Cris Arnou, MSE, MBA
Co-Founder and CEO
Cris Arnou is AgoneX Biopharmaceuticals Inc. Co-Founder and CEO. As a migraine sufferer for more than 35 years he is determined and committed to implementing the migraine treatment and prevention throughout the U.S. via existing medical offices.
In the past, Mr. Arnou has worked for two start-up companies and knows what it takes to build a successful, prosperous business. Additionally, Cris spent 10 years working at Ford Motor Company covering different aspects of product development, marketing and product launch.
Cris holds Bachelor and Master Degrees in Engineering from the University of Michigan, Ann Arbor and an MBA from Wayne State University in Detroit. He is a veteran of the U.S. Army.
Dr. Amy S. Chappell, MD, FAAN
Chief Medical Officer
Dr. Chappell is a board certified neurologist with special competence in child neurology. She retired from Lilly Research Laboratories in January 2014, after 25 years in clinical research where she most recently served as the Neuroscience Senior Medical Fellow. She designed and conducted clinical trials through all phases of development in neurological disorders including epilepsy, ALS, Parkinson’s disease, Alzheimer’s disease, multiple sclerosis, migraine and pain disorders (fibromyalgia, osteoarthritis, chronic low back pain, lumbar radiculopathy, spinal cord injury). She was the lead physician for the development of duloxetine for fibromyalgia, which resulted in an FDA-approval. Dr. Chappell continues to practice neurology, most recently as clinical associate professor at the Indiana University Medical Center.
Randy Jones, JD
Chief Legal Officer and Secretary
Randy Jones is Chief Legal Officer and Secretary for AgoneX Biopharmaceuticals Inc. He is also Principal of Solutions Business Group, which he founded in 2009 as a business services firm dedicated to assisting for-profit and non-profit businesses achieve stretch goals, resolve difficult challenges and navigate periods of change or transition. Prior to founding Solutions Business Group, Mr. Jones spent more than 20 years working for global corporations in a wide range of industries including pharmaceuticals, biotech, energy and chemicals. His distinguished career encompasses a variety of roles including engineer, in-house legal counsel and senior executive in charge of legal, human resources, corporate compliance and ethics. Mr. Jones also spent 6 years as General Counsel of TalecrisBiotherapeutics, a company that reached a $4.4B market cap. Mr. Jones holds a Bachelor of Chemical Engineering from the University of Delaware and a Juris Doctor from the University of Virginia.